Loading...
Incannex Healthcare Limited
IHL.AX•ASX
Healthcare
Drug Manufacturers - Specialty & Generic
A$0.04
A$-0.00(-10.87%)
Incannex Healthcare Limited (IHL.AX) Financial Performance & Statements
Review Incannex Healthcare Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
39.52%
↑ 39.52%
Net Income Growth
62.18%
↑ 62.18%
Operating Cash Flow Growth
-47.41%
↓ 47.41%
Operating Margin
-1746.78%
↓ 1746.78%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-1970.61%
↓ 1970.61%
ROE
-33.30%
↓ 33.30%
ROIC
-20.90%
↓ 20.90%
Incannex Healthcare Limited (IHL.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Incannex Healthcare Limited stock.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2022 |
|---|---|---|---|---|
| Revenue | $12000.00 | $12000.00 | $0.00 | $506939.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $12000.00 | $12000.00 | $0.00 | $506939.00 |
| Gross Profit Ratio | $1.00 | $1.00 | $0.00 | $1.00 |
| R&D Expenses | $1.41M | $4.36M | $2.64M | $2.48M |
| SG&A Expenses | $3.60M | $5.40M | $5.34M | $2.53M |
| Operating Expenses | $5.02M | $9.76M | $7.98M | $6.35M |
| Total Costs & Expenses | $5.02M | $9.76M | $7.98M | $6.35M |
| Interest Income | $28000.00 | $40000.00 | $20000.00 | $120888.00 |
| Interest Expense | $171000.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $126000.00 | $62000.00 | $12000.00 | $6954.00 |
| EBITDA | -$5.60M | -$6.40M | -$5.24M | -$4.53M |
| EBITDA Ratio | -$466.42 | -$533.17 | $0.00 | -$8.94 |
| Operating Income | -$5.004M | -$9.74M | -$7.98M | -$4.54M |
| Operating Income Ratio | -$417.00 | -$812.00 | $0.00 | -$8.96 |
| Other Income/Expenses (Net) | -$890000.00 | $3.31M | $2.74M | -$1.18M |
| Income Before Tax | -$5.89M | -$6.43M | -$5.24M | -$5.73M |
| Income Before Tax Ratio | -$491.17 | -$535.92 | $0.00 | -$11.29 |
| Income Tax Expense | $0.00 | $30000.00 | $0.00 | $0.00 |
| Net Income | -$5.89M | -$6.46M | -$5.24M | -$5.73M |
| Net Income Ratio | -$491.17 | -$538.42 | $0.00 | -$11.29 |
| EPS | -$0.33 | -$0.38 | -$0.33 | -$0.003 |
| Diluted EPS | -$0.33 | -$0.38 | -$0.33 | -$0.003 |
| Weighted Avg Shares Outstanding | $17.62M | $17.04M | $15.87M | $1.68B |
| Weighted Avg Shares Outstanding (Diluted) | $17.62M | $17.04M | $15.87M | $1.68B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan